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Brief review
In 1903 Maurice Garin’s inaugural victory over 
2428 km (94 h:33 min) in the Tour de France (Tour) 
established a 109-year legacy of bicycle racing. Today, 
59 cyclists have won the Tour, in which, in its infancy, 
cyclists attended to their own maintenance, feeding, and 
hydration needs.1 Today’s modern Tour is well supported 
and composed of 3 stage types: flat (FT), high mountain 
(HM), and time trial (TT). While the first few Tours were 
<3000 km long, these soon evolved into the grueling, clas-
sic editions (>5000 km) composed of FTs divided into 14 
to 17 stages (³400 km/stage). This peaked in 1927 (5745 
km, 17 stages, ~337-km stage) with each stage lasting ~14 
hours. It was also during this time that HM stages were 
introduced in the Pyrenees (Tourmalet and Aubisque, 
1910) and the Alps in 1911 (Galibier),1 and 1934 saw the 
introduction of the more classic TT. The shorter prologue 
TT was introduced in 1967. In 1952, coinciding with the 
Tour’s first television coverage, the Tour finished its HM 
stages on the top of respective climbs (Alpe D’Huez, Puy 
de Dome, and Sestrières), and in 1957, it was broadcast 
for the first time in its entirety, increasing the impact of 
the race among the general public.
The modern era of the Tour started in the 1980s with 
the inclusion of technological advances such as clip-on 
pedals and aerodynamic components (eg, TT helmets, 
aerobars, special bike frames, disc wheels).2 Among 
the 59 Tour winners, 3 riders won the Tour 3 times, 4 
riders won 5 times, and 1, Lance Armstrong, was able to 
win the Tour 7 times. Paradoxically, it was not until the 
past 50 years that the level of specialization for cyclists 
increased and the great masters of the Tour emerged: 
Jacques Anquetil in the 60s, Eddie Merckx in the 70s, 
Bernard Hinault in the 80s, Miguel Indurain in the 90s, 
and Lance Armstrong after the year 2000.1 Today, the 
Tour remains the largest sporting event that is free to 
most of those who attend, who line the roadsides from 
start to finish in the hope of catching a brief glimpse of 
their racing heroes.
Although the distance has gradually decreased from 
1927, the Tour has maintained its current configuration of 
~21 stages raced over 3 weeks1 and allows for the analysis 
of changes in the estimated physiological requirements 
through the present day. Concordant with the decreased 
distance is an increase in the winner’s average speed, 
reaching its zenith in 2005 (41,654 km/h; Figure 1).1 
Indeed, if the first 3 Tours are excluded (<3000 km), we 
observe a high correlation between the total race distance 
and the average speed of the winner (r = –.889, P < .01; 
Figure 2). This observation also suggests the obvious 
influence of the cyclist’s ability to sustain high exercise 
intensities and greater speeds for prolonged periods of 
time (Figures 3 and 4). While the total race distance has 
varied less, in modern times (1985–2011) technological 
advances (modern bike frames, clip-on pedals, aerody-
namic positioning, aerodynamic bike components, road 
surfaces, etc) have contributed to the improvements in 
racing speeds observed today despite the same physi-
ological load (r = –.511, P < .01).2
Today’s modern Tour begins with ~200 cyclists who 
cover an average distance of 3650 ± 208 km in an average 
of 92 ± 6 hours for the winner (data from 1990 to 2011).1 
FT stages now last ~200 km (4–5 h) and are ridden at 
high speeds (40–60 km/h) mostly in a group, known as 
the peloton, which demands high technical abilities. The 
TT stages, where specialists maintain high speeds (~50 
km/h) without drafting, depend on a high, sustainable 
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From its initial inception in 1903 as a race premised on a publicity stunt to sell newspapers, the Tour de 
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Figure 1 — Total distance covered and average speed of the winners of the Tour de France (1903–2011). Interruptions are the 2 
periods of noncelebration due to World Wars I and II (1915–1918 and 1940–1946). The fastest wins of the Tour de France’s great 
dominators (≥5 victories) are also shown: cyclist’s name, year (speed in km/h).
power output and aerodynamics to be successful, Finally, 
the HM stages (~200 km, 5–6 h) often include eclipsing 
several mountain passes, thus demanding several bouts 
of 45 minutes or more at high intensities2 (Table 1).
Anthropometric and Physiological 
Profile of Tour Cyclists
Stature
Most Tour participants are white,2 with the winners 
being an average age of 28 ± 3 years old (range 20–36 
y).1 Recently (1985–2011) this age has narrowed to 29 
± 3 years (24–34 y),1 which might denote a greater spe-
cialization for winners of the current generation of Tour 
winners. The anthropometric profile of Tour participants 
(body weight, height, body surface area, and body-mass 
index [BMI]) also appears to determine, at least in part, 
success during the different types of stages.3 For example, 
TT specialists are generally 180 to 185 cm tall, weigh 70 
to 75 kg, and have a BMI ~22 kg/m2. This anthropometry 
allows them to achieve higher absolute power outputs (W) 
than climbers (175–180 cm, 60–66 kg, BMI 19–20 kg/
m2), who are better able to maintain higher relative power 
outputs (W/kg).3,4 Although there are Tour winners with a 
climber-like anthropometry (eg, Marco Pantani, 173 cm 
and 57 kg), the profile of the 10 winners from the last 2 
decades (Miguel Indurain to Cadel Evans) is much closer 
to that of TT specialists (179.1 ± 6 cm and 67.4 ± 7 kg).1 
Cardiorespiratory Capacity
The maximum oxygen uptake (VO2max) of most Tour 
participants varies from 5.0 to 5.5 L/min or 70 to 80 
mL · kg–1 · min–1.5–14 The highest values (~80 mL · kg–1 
· min–1) usually correspond to climbers (body mass <70 
kg), with the values of the top 10 riders ranging from 5.3 
L/min (76 mL · kg–1 · min–1) to 5.8 L/min (82 mL · kg–1 
· min–1). For race winners, the VO2max has ranged from 
6.1 L/min (81 mL · kg–1 · min–1)15 to 6.4 L/min (79 mL 
· kg–1 · min–1).16 We have registered a VO2max of 86 mL · 
kg–1 · min–1 in a Tour winner.14 Collectively, these values 
suggest a minimum threshold of 80 mL · kg–1 · min–1 to 
win the Tour.
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Figure 2 — Relationship between the total distance and winner’s average speed in the Tour de France.
Power Output
The maximum power (Wmax) achieved by Tour cyclists 
during exercise testing varies by protocol. During ramp 
protocols (workload duration ≤1 min), Wmax ranges 
from 450 to 500 W (6.5–7.5 W/kg).4,8,9,11,17,18 For stage 
protocols (workload increments every 4 min), Wmax is 
usually 400–450 W (6.0–6.5 W/kg).3,14 Under both cir-
cumstances, higher values are generally observed in TT 
specialists,4,16 while the top-10 Tour cyclists can reach 
500–550 W (7–7.7 W/kg) during ramp protocols8 and 
572 W (~7.1 W/kg) during longer protocols such as those 
reported in 5-time winner Miguel Indurain.16
Submaximal Thresholds
The lactate threshold and the onset of blood lactate 
accumulation (denoting the workload eliciting a blood 
lactate concentration of ~4 mM/L) usually corre-
spond to ~330 W (76% Wmax or 77% VO2max) and 386 
W (87% Wmax or 86% VO2max), respectively.5,6,13,19,20 
In ramp protocols, using ventilatory methods, Tour 
participants reach the first ventilatory threshold (VT, 
approximately equivalent in physiological terms to lac-
tate threshold) at 315–370 W (~70% Wmax or 70–75% 
VO2max) and the respiratory compensation point (RCP, 
approximately physiologically equivalent to onset of 
blood lactate accumulation) at 400–450 W (~90% Wmax 
or ~90% VO2max).6,7,19,21 These values are significantly 
higher than those reported in elite cyclists, who gener-
ally report lower VT (~60% Wmax, ~60% VO2max) and 
RCP (~84% Wmax, ~80% VO2max).9,10 The power output 
at the VT is correlated with performance in TT stages of 
the Tour,19 and the best TT specialists or Tour winners 
are able to maintain higher wattages at onset of blood 
lactate accumulation (eg, 505 W, 6.2 W/kg for Miguel 
Indurain16).
Efficiency
Tour cyclists also show high gross mechanical efficiency 
(GE) or delta efficiency and cycling economy (CE) at 
high loads of exercise.8,14 For example, the best cyclists 
in the Tour (top-10 and several stages winners) have 
GE and CE values of ~24% and ~85 W/L, respectively, 
measured during a constant-load test at 80% VO2max 
(~385 W).8 The GE can be even higher in Tour winners, 
for example, 25% at ~500 W.16 Although GE generally 
depends on the percentage of type I fibers in the quad-
riceps muscle,22 there are no data on Tour cyclists sup-
porting this premise with biopsies. However, it has been 
reported that professional cyclists (non-Tour competitors) 
have a higher percentage of type I fibers (64% in total), 
mitochondrial volume (4.3%), and capillary density for 
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Figure 3 — Relationship between the total distance and winner’s average speed in the Tour de France (except the first 3, which 
were less than 3000 km).
all types of fibers (mean of 589 capillaries/mm2) than their 
nonprofessional peers.23 A high percentage of type I fibers 
has also been suggested as an important contributor to 
the high GE and CE values reported in Tour participants 
and winners.8,14,15 It has also been reported that muscle 
efficiency (expressed as delta efficiency) increases over 
the years in top-level Tour cyclists, especially in those 
with comparatively lower VO2max.14 A good example of 
the performance advantage brought about by high muscle 
efficiency is the trend to adopt higher cadences (>90 
rpm) by professional cyclists since Lance Armstrong 
began to adopt this pattern in the legendary ascents of 
Sestriere (1999), Hautacam (2000), and Alpe d’Huez 
(2001), where it is estimated that Armstrong maintained 
a power output of ~450 W during Alpe d’Huez.2 Contrary 
to other athletes (including amateur cyclists), professional 
cyclists seem to be more efficient when pedaling at high 
cadences.12 Indeed, when pedaling at a constant load (eg, 
~370 W on average), GE has been shown to be 22.4%, 
23.6%, and 24.2% at 60, 80, and 100 rpm, respectively, 
in top-level Tour cyclists.12 It has been hypothesized that 
the lower muscle force exerted at high cadences could 
improve increasing venous return while decreasing the 
occlusion effect of quadriceps muscle on capillaries and 
arterioles.24,25
Physiological Demands  
During the Tour de France
Although it is possible to estimate the physiological 
demands of the Tour based on history books, more robust 
advances in the scientific quantification of Tour demands 
began in the early 90s with the introduction of heart-
rate monitors.2,26 Three different approaches have been 
described using this technology. The first method charac-
terizes the absolute amount of time a cyclist spends at dif-
ferent intensities during each stage and race5,6,13,17,21,27,28 
and is generally structured into zones corresponding to 
heart rates obtained in a previous maximal incremental 
cycle-ergometer test: zone 1 (HR < VT), <70% VO2max), 
zone 2 (HR between VT and RCP, 70–90% VO2max), and 
zone 3 (HR ≥ RCP, >90% VO2max).2 The physiological 
requirements of Tour have also been quantified in terms 
of power output (W) generated during the competition, 
with power output being estimated from the HR in 
competition and according to the HR–W relationship 
measured in the laboratory13,19,21,27–29 or measured directly 
during competition.30 Finally, the third method, which 
accounts for the internal physiological load generated 
during the Tour,21,27,31 is quantified by recording training 
impulses (TRIMPs), whereby the first method’s zones are 
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Table 1 Characteristics of the 3 Main Competition Requirements of the Modern Tour de France 
(From the 1990s to Today)
Flat stages High mountain stages Time-trial stages
Distance (km) ~200 ~200 30–55
Exercise time (h) 4–5 5–6 ≤1a
Mean exercise intensity Low to moderate 
(Zones 1–2)
Moderate to high 
(Zones 2–3 during ascents)
High 
(Zones 2–3).
Mean velocity (km/h) ~45 ~20 (during ascents) ~50 (time-trial specialists)
Cycling position Traditional (sitting) Alternating (sitting and standing) Aerodynamic (triathlon bars)
Main requirements Technical Physiological Physiological and aerodynamic
Specific concerns Crashes Moderate hypoxia 
(altitude > 1500 m)
Aerodynamics
Estimated mean power output 200–250 W ≥6 W/kg in climbers 350 W (≥400 W in time trialists)
Physiological load (TRIMP) b ≤350 ≥500 120–180 
a Dates from last 5 Tours (2007–2011), obtained from Augendre (Tour de France’s historical guide).
b Dates from Lucía et al21 and Earnest et al.19
Figure 4 — Relationship between the total distance and winner’s average speed in the “modern” Tour de France, 1985–2011 
(modern bicycle equipment was introduced in 1985).
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 multiplied by 1, 2, and 3 TRIMPs for each minute the 
cyclist performs in zones 1, 2 and 3 respectively, and then 
adding all zones to obtain total TRIMPs.21
FT Stages
On average, and, keeping in mind that cardiac drift will 
alter the HR–W relationship,2 70% of the total time during 
FT stages is spent in zone 1, 25% in zone 2, and only 5% 
in zone 3,5,27 or ~195, 82, and 21 min/d in each respec-
tive zone.5 The technical requirements during FT stages 
are very important,2 as cyclists ride close together in the 
peloton trying to minimize air resistance by drafting as 
efficiently as possible.32 In these stages, pedal cadence is 
~90 rpm28 and cyclists typically maintain power outputs 
of 200–250 W.2,27
HM Stages
HM stages range in difficulty from 1 to 4 (hardest to 
least difficult) but also contain Hors-category (translated 
as “outside” or other category) climbs, which represent 
the most difficult, and first-category climbs (hardest on 
to Hors on a scale of 1–4), each comprised of a distance 
often above 10 km. Climbs of this category can range up 
to 10 km in length, 5% to 10% in gradient,2 and have an 
altitude of ~2000 m, so that reduced oxygen availability 
imposes an additional physiological challenge.2 These 
climbs can demand work at intensities ≥90% VO2max33 
but should not surprise the reader. It should be remem-
bered that the Tour was originally formed as a means of 
garnering publicity for the French newspaper L’Auto, 
by Henri Desgrange, who was no stranger to meting out 
punishing rides in order to gain publicity; this prompted 
the 1910 winner, Octave Lapize, to chastise officials—
“You are assassins, yes, assassins!”—while climbing the 
first-ever HM stages of the Tour in the Pyrenees that day.
Padilla et al13 analyzed the exercise intensity in 
climbs to mountain passes (68 Hors category, 172 first 
category, and 134 second category) of the 3 Grand Tours 
(Giro d’Italia, Vuelta a España, and Tour) and reported the 
average intensity (%HR reserve) during the ascents to be 
77% in Hors and first-category passes and 74% in second-
category mountain passes and always synonymous to the 
HR corresponding to onset of blood lactate accumulation. 
In addition, the authors described how the moment of 
the stage where the pass is located (first, second, or third 
part of the stage) strongly influences exercise intensity. 
Specifically, Hors and first-category passes in the second 
and final thirds of a stage are covered at higher intensi-
ties than those at the beginning.13 When just the Tour 
is analyzed, it has been reported that cyclists maintain 
approximately 158, 107, and 35 minutes in zones 1, 2, and 
3, respectively, with a higher percentage of time spent in 
zone 3 than in the HM stages of the Vuelta.5 It has been 
estimated that riders maintain an average power output 
of 322 W during the climbs to the Hors and first-category 
mountain passes, with the highest values achieved in the 
ascents during the middle third of the stage (385 W and 
345 W for Hors and first-category passes, respectively).13 
Due to the fight against gravity, a high power:body-weight 
ratio (ie, ≥6 W/kg at VO2max) is a prerequisite to perform 
successfully in these stages.3,4
TT
The Tour also includes TT stages that include 1 prologue 
(5–10 km) and 2 long TTs (40–60 km). Occasionally a 
team TT stage is also included.2 During the TT stages, 
the technical and aerodynamic requirements of the cyclist 
focus on posture in order to reduce frontal body surface 
area and bicycle componentry to maximize aerodynamic 
efficiency.33 In fact, aerodynamic resistance represents 
90% of the whole resistance encountered by the riders 
at speeds >30 km/h and, thus, is a major determinant of 
performance in TT stages.26 In addition, TT stages require 
the cyclist to maintain high intensities of exercise for 
long periods of time, with high pedal cadences (90–100 
rpm)2,26 such that TT specialists are able to maintain a 
higher percentage of time in zone 3. Thus, it has been 
estimated that TT specialists are able to maintain ~400 
W for up to 60 minutes in long TTs (>40 km),28 although 
on average, the estimated power output of most riders is 
lower, ~350 W.31 Recently, Earnest et al19 described the 
effort involved in TTs by analyzing HR data from 26 
riders who competed in 35 TT stages from different edi-
tions of the Tour and Vuelta; results indicated that in the 
21 long TTs (average distance ~48 km) and in 4 team TTs 
(average distance ~44 km), the cyclists who intended to 
contend for the stage victory or to reach a high position 
in the overall race standings were able to maintain >430 
W for ~26 and ~20 minutes (in individual and team TTs, 
respectively).19
Lucia et al17 also described the estimated power 
maintained by cyclists in 3 long TTs in the Tour—2 of 
them held in the first week and 1 in the last week after 
19 days of competition—thus with considerable fatigue 
accumulation. In 1 of the 2 first TTs (1999 Tour, 56.5 
km), cyclists maintained an average power >402 W (6.2 
W/kg) for ~40 minutes. In the other TT (1998 Tour, 58 
km including a third-category mountain pass), the riders 
were able to maintain an average power >458 W (6.6 W/
kg) for an average time of nearly 53 minutes,17 which 
today is the highest average power estimated for a TT 
during the Tour. Yet this value is considerably lower than 
the estimated average power output of 5-time winner 
Miguel Indurain during the 1-hour world record in a 
velodrome (that he set in 1994), that is, nearly 510 W (6.3 
W/kg).16 Perhaps one of the most compelling examples 
of aerodynamic efficiency in the TT was in 1989 by Greg 
LeMond, who trailed Tour favorite Lauren Fignon by 50 
seconds on the final day with just a relatively short TT 
(25.5 km) to go. While Fignon eschewed most modern 
technology, LeMond presented at the starting line with 
aerobars on his bike and proceeded to win the Tour by 
8 seconds over Fignon. Despite a brilliant racing career, 
having won 3 Grand Tours (Giro once, Tour twice), the 
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fate of Fignon may rest as the man who lost the 1989 
Tour to aerodynamic advances in the TT.1
Actual Power Output Levels  
in the Tour de France
Both the rider’s position on the bike (standing vs seated)26 
and cardiovascular drift, produced by dehydration and 
hyperthermia, can alter the cyclist’s HR levels. Another 
potential confounder of using HR data to estimate 
exercise intensity during 3-week races comes from the 
fact that maximum HR tends to decrease during the 
event, especially during the last week of competition.2 
Now, power sensors (eg, SRM and PowerTap) can be 
used to quantify the physiological demands of 3-week 
races. These sensors have been validated34,35 and allow 
riders, coaches, and scientists to examine the external 
load (in watts) during cycling competitions,36 as well as 
comparing wattage results with those derived from HR 
data in the aforementioned intensity zones.36 To the best 
of our knowledge, no actual published data on power 
output are available during the Tour. However, there are 
examples from 5 to 6 FT stages of 1-week tour races, 
in which professional cyclists also experienced in Tour 
riding maintain, on average, a power output of 220 ± 22 
W (3.1 ± 0.2 W/kg)36 to 250 ± 30 W (3.8 ± 0.4 W/kg)37 
and during climbs and TT reach an average of 392 ± 60 
W (5.5 ± 0.4 W/kg).36
One case study conducted during the 2005 Giro 
reported mean power output levels of 132 ± 26 W (2 ± 
0.2 W/kg) during FT stages versus 235 ± 30 W (3.5 ± 0.1 
W/kg) in HM stages, with peak values of 367 W that were 
maintained for 30 minutes in the HM stages.38 Another 
finding of that case study was that FTs were characterized 
by a large variability of power output, with short bursts 
of high power and long periods with reduced intensity 
of exercise, whereas HM mostly required submaximal, 
constant power output over longer periods. These fluc-
tuations in power during FS likely occur relative to the 
degree a cyclist rides in the midst of the peloton, versus 
near the front, where more work is required. While we 
are unaware of any published data to the contrary, other 
case studies using the SRM in a few cyclists allow us to 
hypothesize that the aforementioned published values 
in 1 cyclist during the Giro fall below those achieved by 
the best Tour contenders. For instance, in the 2011 Tour, 
the average power maintained by several domestique (eg, 
servant or helper) cyclists in HM stages ranged from 249 
to 331 W, with peaks of 337 to 417 W (maintained for 20 
min).30 Moreover, an average power of 383 W (6.0 W/
kg) was maintained by 1 cyclist for more than 32 minutes 
during the ascent to Galibier in stage 19.30 One rider rode 
with the overall victory candidates for 26 seconds in the 
ascent to Galibier; keeping pace with the best riders 
required that he maintain 471W (7.3 W/kg) during this 
short period of time.30 In the same Tour (2011), another 
cyclist (who finished the stage 4 min:20 s behind the 
stage winner) maintained 397 W for ~1 hour.39 While 
more data are needed to support these individual obser-
vations, these case studies suggest that the strong men 
of the Tour may be able to maintain even higher power 
levels than those observed in the domestiques. Keeping 
in mind that these are individual data, these power output 
values do not differ essentially from published estimates 
based on the HR:W ratio obtained in the laboratory.19,28,31 
Although several cycling teams use power meters during 
training and competitions, the lack of published studies 
with these devices implies that, still, in order to estimate 
the actual power output during the Tour, we must rely 
on studies that quantify power output according to the 
HR–W relationship.2,19,20,27,28,31
Physiological Load  
of the Tour (TRIMPs)
The physiological load (in terms of TRIMPs) of the 
Tour has been studied together to that of the Vuelta and 
Giro,13,19,21,27,29,31 or together with that of shorter (1-wk) 
tour races.31 As for the Tour, the mean TRIMP value is 
7112 ± 289 for a mean total race duration of ~91 hours 
and 51 minutes.21 Lucia et al21 first described the actual 
requirement of the Tour by analyzing the internal load of 
7 cyclists in 4 Tours and Vueltas (1997, 1999, 2000, and 
2001). Although the 2 races were different, with a greater 
total distance in the Tour and a less clear differentiation 
between “pure” FT and “pure” HM in the Vuelta, the 
typical FT stages were less demanding (≤350 TRIMPs) 
in the Tour than in the Vuelta, yet the total TRIMP load 
was similar in both races.21 Nevertheless, the HM and TT 
stages, in which the cyclists spend long periods of time 
in zone 32,5,6,27,31,33 and which decide the final outcome 
of the race,2 are those that characterize the Tour as the 
hardest race. The HM stages are more demanding in the 
Tour (≥500 TRIMPs) than in the Vuelta (~380 TRIMPs).21 
This is because in the Tour, HM stages are longer and 
have more mountain passes and Hors-category parts,21 
whose ascents impose a greater load; that is, each ascent 
involves a load of 115, 72, or 41 TRIMPs for Hors- and 
first- and second-category ascents, respectively.13 In 
fact, HMs are so demanding that the largest loads, ~600 
TRIMPs, are recorded in these stages (total duration >5 
h and ~2 h in zone 3, corresponding to 3–4 ascents of 
~30–40 min each).
The TRIMP value seems to be the limit of daily 
energy expenditure that can be tolerated by humans, 
because 2 consecutive days of 600 TRIMPs have never 
been recorded21 despite the fact that there are 2 or more 
consecutive HM stages in every Tour de France. Keeping 
in mind that the demand of a marathon is ~300 TRIMPs,21 
the high TRIMP values of the Tour, that is, ≥500 TRIMPs 
for several consecutive stages and an average of 350 to 
400 TRIMPs/d over the total 3-week period, would sug-
gest that the Tour is arguably the hardest endurance race 
in the world. It seems that these limits (~600 TRIMPs/d 
and a total of ~7100 TRIMPs) may be regulated at the 
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level of a “central controller” in order to prevent poten-
tially dangerous body disturbances such as hormonal 
exhaustion. In effect, decreases in testosterone, cortisol, 
luteinizing hormone, and melatonin have been described 
in the third week of the Vuelta.40,41 In this sense, there are 
no individual differences in either total load (TRIMPs) 
or accumulated load (~2000 TRIMPs/wk) between the 
Tour and the Vuelta.29 In addition, the pattern of daily 
TRIMP accumulation in 3-week races for a given cyclist 
is similar over the years,29 suggesting a maximal threshold 
limit in the human ability to tolerate strenuous endurance 
exercise. Such a limit would be “predetermined”; that is, 
an anticipation capacity in the regulation of daily energy 
expenditure exists, based both on the cyclist’s previous 
experience (from the past 3-wk races completed) and on 
daily sensory feedback.29 In long TTs (40–60 km), the 
physiological load is ~120 to 180 TRIMPs.19,21 Similar 
to the time spent in each intensity zone, the internal load 
depends largely on the role each rider has in the team. 
Thus, in TTs, the total load (TRIMP) and the percent-
age of TRIMP corresponding to zone 3 (>RCP or >90% 
VO2max) are higher in cyclists who are really competing 
at their best (ie, contenders) than in those without aspira-
tions to victory.19 This difference remains significant even 
in the long team TTs.19
Nutrition and Hydration in the Tour
During early Tours, cyclists had to be self-sufficient in 
all aspects of their racing, including mechanical repairs, 
feeding, and hydration. Per the former, is was in 1913 
that Eugene Christophe was penalized an insulting 
3 minutes for enlisting the aid of a 7-year-old boy to 
pump billows after spending nearly 5 hours seeking out 
a blacksmith and making his own bike-fork repairs when 
he merely needed an extra set of hands to keep up the 
flames. As for feeding and hydration, cyclists often had 
to obtain food in bars along the way and get water from 
fountains.2 At this time, cyclists were not aware of the 
effects of carbohydrate intake on preexercise glycogen, 
fat oxidation, and performance, so the occurrence of 
exercise-induced hypoglycemia (known as “heating the 
bunk”) was frequent.2 Today, carbohydrate intake during 
stages is still rather low (mean 25 g/h), below values that 
allow maximizing the rate of carbohydrate oxidation 
during exercise (30–60 g/h).2 Nevertheless, the daily 
calorie intake of participants in the Tour is high enough 
(23–25 MJ/d) to match the tremendous energy cost of 
competition.42 The cyclists’ carbohydrate intake (>12–13 
g · kg–1 · d–1) seems sufficient to replenish glycogen stores 
within 18 hours—the period that elapses from the end of 
a stage to the time the next day’s stage begins (from ~5 
PM to noon). Especially important is the carbohydrate 
intake (1.1 g/kg) during the first 6 hours after the stage. 
This carbohydrate intake is complemented with protein 
(0.35 g/kg) to increase muscle glycogen resynthesis in 
these first hours of recovery.43 A remarkable aspect is also 
the high protein intake (3 g · kg–1 · d–1) observed during 
Grand Tour events.33 In general terms, during 3-week tour 
races (eg, Vuelta) the daily energy intake corresponds to 
~840 g of carbohydrates, ~200 g of protein, and ~158 g 
of fat.43 Today, hydration levels vary from of 3.3 L/d43 
to 6.7 L/d,42 depending on the amount of carbohydrates 
consumed in liquid form (sports drinks).33
Hematological Variables  
and Blood Doping
From the beginning of Tour various means have been 
used to improve performance. In the first decades, cyclists 
used wine mixed with strychnine, ether-soaked handker-
chiefs, or chloroform rubbed into their gums to reduce 
pain and perception of fatigue.2 In 1967, the Tour saw 
the death of British cyclist Tom Simpson on the slopes 
of Mont Ventoux after he drank a mixture of alcohol and 
amphetamines in extremely hot weather conditions.1 
Probably the most epic disaster of the Tour was in 1998 
when a Festina team car was intercepted carrying recom-
binant human erythropoietin (rhEPO) and other doping 
substances, leading to not only the expulsion of the team 
but also nearly the demise of the Tour itself.
rhEPO increases blood hemoglobin concentration 
([Hb]), VO2max, and performance.2 Despite its early use 
and attempts by the International Cycling Union’s estab-
lishment of a 50% hematocrit (HCT) level as the upper 
limit to compete, rhEPO was not detectable until 2000. 
To date, several riders have exceeded this upper limit and 
have also been removed from the Tour. Research sug-
gests that normal HCT values are 43.0% ± 0.02% (range 
39–48%) as reported by Saris et al,44 who obtained 353 
samples during Tours from 1980 to 1985 and before the 
marketing of rhEPO. Later studies have reported slightly 
higher values for HCT and [Hb] in 177 participants—at 
the beginning of the 2011 Tour being 43.5% to 46.9% and 
14.6 to 15.0 g/dL, respectively.45 Morkeberg et al46 ana-
lyzed hematological and urine variables for blood doping, 
steroids, autologous blood transfusions, and rhEPO in 
a cycling team over an entire racing season. Using 661 
samples from training, precompetition (1–3 d before the 
meeting), and competition periods including the 3 Grand 
Tours and World Championship, the authors observed 
that HCT and [Hb] fell from 45% and 15.2 g/dL from 
December 2006 to 40.7% and 14.0 g/dL on September 
2007. These values then “recovered” to 44.7% and 15.3 
g/dL by November 2007. During the Tour, there was a 
decrease of 11.5% in [Hb] (range 7.0–20.6%), which 
expresses the hematologic adaptation involved the Tour.46 
Paradoxically, the cyclists who participated in that Tour 
showed increases in HCT and [Hb] during the tapering 
period before the Tour,46 making it difficult to determine 
whether these effects were due to doping or tapering 
alterations. In January 2008 the International Cycling 
Union and the World Anti-Doping Agency established the 
biological passport as a control method for hematologi-
cal variations on individual patterns recorded for years. 
Today, this method controls 850 cyclists intensively (eg, 
208  Santalla et al
~20,000 samples in 2008–2009)47 and is more accurate 
than previous methods.48
Summary and Future Perspectives
From its initial inception as a race premised on a pub-
licity stunt to sell newspapers, the Tour de France has 
grown and evolved over time to become one of the most 
difficult and heralded sporting events in the world. Rich 
in history, heroism, high jinks, and controversy, the 
Tour has continued to survive and thrive over the years. 
Though sporting science and the Tour paralleled each 
other, it was not until the midlate 1980s that the 2 began 
to unify and grow together. It is our hope that, with the 
development of technology allowing scientists to measure 
power output, continued scientific inquiry would follow 
the historical precedent of determining the capabilities 
and potential limitations of human endurance. However, 
such aspirations take coordinated research efforts, and 
to date few teams have been willing to take on such an 
agenda. Finally, as with much scientific inquiry, insights 
into molecular biology will surely help in the pursuit of 
linking the physiology of those who are highly trained 
and those experiencing various metabolic diseases.
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